STOCK TITAN

Director Ferrari (LUNG) awarded 40,000 Pulmonx restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ferrari Richard reported acquisition or exercise transactions in this Form 4 filing.

Pulmonx Corp director Richard Ferrari reported an equity award. He received 40,000 shares of common stock through a grant of Restricted Stock Units at a stated price of $0.00 per share. These RSUs vest on the earlier of the one-year anniversary of the June 5, 2026 grant date or the next annual stockholders’ meeting. Following this award, Ferrari directly holds 127,024 Pulmonx shares.

Positive

  • None.

Negative

  • None.
Insider Ferrari Richard
Role null
Type Security Shares Price Value
Grant/Award Common Stock 40,000 $0.00 --
Holdings After Transaction: Common Stock — 127,024 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 40,000 shares Restricted Stock Units granted to director on June 5, 2026
Grant price $0.00 per share Stated price for RSU award
Post-grant holdings 127,024 shares Total Pulmonx common stock held directly after transaction
Vesting trigger date June 5, 2026 One-year anniversary used as one vesting trigger for RSUs
Restricted Stock Units financial
"Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU Grant financial
"Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock"
Annual Meeting of the Stockholders financial
"or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent"
common stock financial
"payable solely in common stock of the Issuer that vest on the earlier"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ferrari Richard

(Last)(First)(Middle)
C/O PULMONX CORPORATION
700 CHESAPEAKE DRIVE

(Street)
REDWOOD CITY CALIFORNIA 94063

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026A40,000(1)A$0127,024D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.
/s/ David Aaron Lehman, Attorney-in-Fact06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Pulmonx Corp (LUNG) report for Richard Ferrari?

Pulmonx Corp reported that director Richard Ferrari received a grant of 40,000 Restricted Stock Units, payable solely in Pulmonx common stock. The award was recorded at a price of $0.00 per share as part of his director compensation.

How many Pulmonx (LUNG) shares does Richard Ferrari hold after this Form 4?

After the reported grant, Richard Ferrari holds 127,024 shares of Pulmonx common stock directly. This total includes the 40,000-share Restricted Stock Unit award disclosed in the filing, reflecting his updated ownership position as a company director.

When do Richard Ferrari’s 40,000 Pulmonx (LUNG) RSUs vest?

Ferrari’s 40,000 Restricted Stock Units vest on the earlier of the one-year anniversary of the June 5, 2026 grant date or the date of the next annual stockholders’ meeting. If that anniversary date is not a business day, vesting moves to the next business day.

Was cash paid for Richard Ferrari’s Pulmonx (LUNG) RSU grant?

No cash was paid for the award. The filing lists 40,000 Restricted Stock Units at a price of $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase of Pulmonx shares.

What type of security did Richard Ferrari receive from Pulmonx (LUNG)?

Ferrari received a grant of Restricted Stock Units that are payable solely in Pulmonx common stock. Once vested, these RSUs convert into shares, aligning his compensation with the company’s equity performance as a director.